| dc.identifier.citation | Berwick, D. M., & Hackbarth, A. D. (2012). Eliminating waste in US health care. Jama, 307(14), 1513-1516. doi:10.1001/jama.2012.362 Boyer, M. (1996). The economics of lung cancer. Lung Cancer, 14(1), 13-17. doi:http://dx.doi.org/10.1016/0169-5002(95)00509-9 Bradley, C. J., Gardiner, J., Given, C. W., & Roberts, C. (2005). Cancer, Medicaid enrollment, and survival disparities. Cancer, 103(8), 1712-1718. doi:10.1002/cncr.20954 Bradley, C. J., Given, C. W., Dahman, B., Luo, Z., & Virnig, B. A. (2007). Diagnosis of advanced cancer among elderly Medicare and Medicaid patients. Med Care, 45(5), 410-419. doi:10.1097/01.mlr.0000256970.19359.2a Bradley, C. J., Given, C. W., & Roberts, C. (2001). Disparities in cancer diagnosis and survival. Cancer, 91(1), 178-188. Center of Disease Control & Prevention, a. N. C. I. (2015). United States Cancer Statistic: 1999-2012, Incidence & Mortality web-based Report. Retrieved from Atlanta, GA: http://www.cdc.gov/cancer/lung/basic_info/index.htm Cipriano, L. E., Romanus, D., Earle, C. C., Neville, B. A., Halpern, E. F., Gazelle, G. S., & McMahon, P. M. (2011). Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value in Health, 14(1), 41-52. doi:http://dx.doi.org/10.1016/j.jval.2010.10.006 Davis, K. L., Goyal, R. K., Able, S. L., Brown, J., Li, L., & Kaye, J. A. (2015). Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer, 87(2), 176-185. doi:10.1016/j.lungcan.2014.11.002 Evans, W. K., Will, B. P., Berthelot, J. M., & Wolfson, M. C. (1996). The economics of lung cancer management in Canada. Lung Cancer, 14(1), 19-29. doi:http://dx.doi.org/10.1016/0169-5002(95)00510-2 Forrest, L. F., Adams, J., White, M., & Rubin, G. (2014). Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. Br J Cancer, 111(9), 1843-1851. doi:10.1038/bjc.2014.472 Gogineni, K., Shuman, K. L., & Emanuel, E. J. (2013). Survey of Oncologists about Shortages of Cancer Drugs. New England Journal of Medicine, 369(25), 2463-2464. doi:doi:10.1056/NEJMc1307379 Greenwald, H. P., Polissar, N. L., Borgatta, E. F., McCorkle, R., & Goodman, G. (1998). Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health, 88(11), 1681-1684. Groth, S. S., Al-Refaie, W. B., Zhong, W., Vickers, S. M., Maddaus, M. A., D'Cunha, J., & Habermann, E. B. (2013). Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer. Ann Thorac Surg, 95(4), 1221-1226. doi:10.1016/j.athoracsur.2012.10.079 Halpern, M. T., Ward, E. M., Pavluck, A. L., Schrag, N. M., Bian, J., & Chen, A. Y. (2008). Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol, 9(3), 222-231. doi:10.1016/s1470-2045(08)70032-9 Hirsch, F. R., Fischer, J. R., Niklinski, J., & Zöchbaüer-Müller, S. (2002). Future developments in the treatment of lung cancer. Lung Cancer, 38, Supplement 3(0), 81-85. doi:http://dx.doi.org/10.1016/S0169-5002(02)00277-5 IOM. (2001). Crossing the quality chasm: The IOM Health Care Quality Initiative. Retrieved from http://www.iom.edu/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx Jeon, Y.-H., Essue, B., Jan, S., Wells, R., & Whitworth, J. A. (2009). Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Services Research, 9, 182-182. doi:10.1186/1472-6963-9-182 Joyce, M., Schwartz, S., & Huhmann, M. (2008). Supportive Care in Lung Cancer. Seminars in Oncology Nursing, 24(1), 57-67. doi:http://dx.doi.org/10.1016/j.soncn.2007.11.013 Kanashiki, M., Satoh, H., Ishikawa, H., Yamashita, Y. T., Ohtsuka, M., & Sekizawa, K. (2003). Time from finding abnormality on mass-screening to final diagnosis of lung cancer. Oncol Rep, 10(3), 649-652. Kathuria, H., Gesthalter, Y., Spira, A., Brody, J. S., & Steiling, K. (2014). Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel), 6(2), 1157-1179. doi:10.3390/cancers6021157 Lee, K., Kloecker, G., Pan, J., Rai, S., & Dunlap, N. E. (2013). The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and Its Impact on Survival. Am J Clin Oncol. doi:10.1097/COC.0b013e3182a5346d Lengerich, E. J., Tucker, T. C., Powell, R. K., Colsher, P., Lehman, E., Ward, A. J., . . . Wyatt, S. W. (2005). Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia. J Rural Health, 21(1), 39-47. Macbeth, F. R., Abratt, R. P., Cho, K. H., Stephens, R. J., & Jeremic, B. (2007). Lung cancer management in limited resource settings: Guidelines for appropriate good care. Radiotherapy and Oncology, 82(2), 123-131. doi:http://dx.doi.org/10.1016/j.radonc.2006.12.006 Mariotto, A. B., Yabroff, K. R., Shao, Y., Feuer, E. J., & Brown, M. L. (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 103(2), 117-128. doi:10.1093/jnci/djq495 McDavid, K., Tucker, T. C., Sloggett, A., & Coleman, M. P. (2003). Cancer survival in Kentucky and health insurance coverage. Arch Intern Med, 163(18), 2135-2144. doi:10.1001/archinte.163.18.2135 Mulligan, C. R., Meram, A. D., Proctor, C. D., Wu, H., Zhu, K., & Marrogi, A. J. (2006). Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol Biomarkers Prev, 15(1), 25-31. doi:10.1158/1055-9965.epi-05-0537 Nadpara, P. A., Madhavan, S. S., Tworek, C., Sambamoorthi, U., Hendryx, M., & Almubarak, M. (2015). Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States. J Geriatr Oncol. doi:10.1016/j.jgo.2015.01.001 Paskett, E. D., Fisher, J. L., Lengerich, E. J., Schoenberg, N. E., Kennedy, S. K., Conn, M. E., . . . Dignan, M. (2011). Disparities in underserved white populations: the case of cancer-related disparities in Appalachia. Oncologist, 16(8), 1072-1081. doi:10.1634/theoncologist.2011-0145 Porter, M. E. (2010). What Is Value in Health Care? New England Journal of Medicine, 363(26), 2477-2481. doi:doi:10.1056/NEJMp1011024 Ramsey, S. D., Howlader, N., Etzioni, R. D., & Donato, B. (2004). Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare. J Clin Oncol, 22(24), 4971-4978. doi:10.1200/jco.2004.05.031 Ramsey, S. D., Zeliadt, S. B., Richardson, L. C., Pollack, L., Linden, H., Blough, D. K., & Anderson, N. (2008). Disenrollment from Medicaid after recent cancer diagnosis. Med Care, 46(1), 49-57. doi:10.1097/MLR.0b013e318158ec7f SEER. (7 February 2015). US Lung Cancer Mortality Rate. Retrieved from http://seer.cancer.gov/csr/1975_2011/browse_csr.php?sectionSEL=15&pageSEL=sect_15_table.01.html Sprandio, D. J. (Producer). (2015). The Oncology Medical Home: The Case of Change. Retrieved from http://www.medscape.org/viewarticle/836396?src=wnl_cme_revw www.lung-cancer.com. | in_ID |
